CD44 is a cell membrane glycoprotein which involved in diverse tumor aggressive processes including invasion, proliferation, apoptosis, and angiogenesis (37), but there are no studies reporting its activity in glioma immunity. This evidence concerns the gene CD44 and central nervous system cancer.